background
sarscov
bind
stimul
activ
result
map
surfac
interact
demonstr
surfac
play
critic
role
sarscov
replic
core
interact
domain
essenti
sarscov
replic
signific
core
repres
attract
target
antivir
drug
develop
variou
pathogen
coronavirus
rnasynthes
machineri
sever
acut
respiratori
syndrom
coronaviru
sarscov
compos
nonstructur
protein
encod
acid
subunit
contain
two
zinc
finger
known
interact
stimul
respect
exoribonucleas
activ
use
alaninescan
mutagenesi
cellulo
bioluminesc
reson
energi
transfer
experi
vitro
pulldown
assay
identifi
key
residu
surfac
interact
function
consequ
mutat
introduc
posit
first
evalu
biochem
monitor
exoribonucleas
activ
disrupt
interact
abrog
activ
exoribonucleas
show
surfac
interact
overlap
surfac
involv
activ
activ
suggest
major
regul
sarscov
replicas
function
line
notion
revers
genet
experi
support
essenti
role
surfac
interact
sarscov
replic
sever
mutat
abolish
interact
vitro
yield
replicationneg
viral
phenotyp
contrast
mutant
interact
disturb
prove
crippl
viabl
experi
impli
surfac
interact
possibl
subunit
viral
replic
complex
may
target
develop
antivir
compound
pathogen
coronavirus
virus
order
nidoviral
includ
coronavirida
arterivirida
ronivirida
propos
mesonivirida
famili
possess
largest
rna
genom
known
date
coronavirus
cov
respiratori
enter
pathogen
human
domest
anim
also
appear
omnipres
wildlif
particular
bat
rodent
capabl
cross
speci
barrier
appear
widespread
cov
featur
endem
human
cov
thought
transmit
anim
host
point
past
cov
caus
lifethreaten
zoonot
infect
emerg
human
less
decad
apart
cov
caus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
emphas
signific
pandem
potenti
member
viru
famili
sarscov
presum
emerg
bat
china
spread
around
globe
month
result
regist
case
fatal
rate
merscov
emerg
middl
east
thu
far
result
laboratoryconfirm
case
fatal
rate
around
sarscov
genom
singlestrand
positivesens
rna
kb
viru
entri
genom
translat
initi
complex
gene
express
program
regul
translat
posttransl
transcript
level
open
read
frame
orf
occupi
twothird
genom
translat
directli
genom
yield
two
larg
polyprotein
pp
precursor
call
latter
deriv
extens
sequenc
ribosom
frameshift
near
end
give
rise
fix
ratio
synthesi
ribosom
frameshift
effici
report
two
replicas
polyprotein
cleav
total
function
protein
see
fig
call
nonstructur
protein
viral
rna
synthesi
entail
genom
replic
proce
via
fulllength
minusstrand
rna
synthesi
extens
nest
set
subgenom
mrna
subgenomelength
minusstrand
templat
subgenom
mrna
use
express
structur
accessori
protein
encod
third
genom
see
fig
replicas
polyprotein
cleavag
sarscov
nsp
assembl
multienzym
replicationtranscript
complex
associ
membran
structur
deriv
modif
host
cell
endoplasm
reticulum
although
function
cov
nsp
remain
elus
thu
far
eg
enzymat
activ
attribut
mani
other
commonli
found
rna
viru
world
eg
proteas
helicas
rna
polymeras
function
wherea
other
rare
even
uniqu
includ
eg
endoribonucleas
unknown
function
exoribonucleas
implic
primit
form
proofread
enhanc
fidel
cov
rna
synthesi
detail
pleas
refer
review
ref
cov
genom
also
encod
protein
requir
format
modif
cap
structur
present
end
coronavir
mrna
eukaryot
cell
mrna
invad
virus
host
modifi
addit
cap
protect
degrad
exoribonucleas
ensur
effici
translat
case
viral
mrna
help
prevent
recognit
host
innat
immun
system
eukaryot
cell
cap
ad
cotranscript
nucleu
sequenti
activ
four
enzym
rna
triphosphatas
ii
guanylyltransferas
iii
mtase
iv
yield
socal
structur
gpppn
biolog
import
latter
structur
underlin
fact
numer
virus
evolv
strategi
secur
presenc
terminu
mrna
review
see
ref
positivestrand
rna
virus
like
sarscov
replic
cytoplasm
therefor
presum
access
host
cell
cap
machineri
nevertheless
end
cov
mrna
thought
carri
cap
produc
concert
action
sever
viral
enzym
mani
positivestrand
rna
virus
rna
triphosphatas
activ
embed
rna
helicas
carri
like
mediat
first
step
viral
cap
synthesi
guanylyltransferas
activ
involv
cov
cap
synthesi
remain
elus
thu
far
contrast
two
cov
methyltransferas
activ
identifi
assign
ctermin
domain
methyltransferas
recent
demonstr
vitro
activ
sarscov
depend
interact
complex
exhibit
potent
mtase
activ
specif
convert
gpppn
structur
residu
long
contain
two
zinc
finger
overexpress
rel
encod
although
structur
solv
almost
year
ago
fig
enzymat
function
identifi
propos
protein
togeth
replicas
subunit
implic
format
cov
replicationtranscript
complex
process
like
base
larg
repertoir
specif
interact
nsp
nsp
viral
rna
sequenc
interact
character
biochem
structur
deciph
molecular
basi
function
activ
activ
sever
key
residu
interact
identifi
find
subsequ
support
crystal
structur
complex
recent
observ
rna
cap
may
mandatori
avoid
delay
viral
rna
recognit
innat
immun
sensor
highlight
import
complex
covhost
interplay
use
bioinformat
biochemistri
exoribonucleas
exon
activ
identifi
cov
catalyt
residu
dedd
map
ntermin
part
protein
subsequ
methyltransferas
activ
involv
viral
mrna
cap
identifi
ctermin
domain
protein
methyltransferas
domain
seem
function
separ
exon
domain
predict
interact
recent
confirm
vitro
bouvet
et
al
studi
demonstr
second
regulatori
role
sarscov
upon
interact
exon
activ
increas
use
divers
rna
substrat
exon
activ
shown
specif
degrad
doublestrand
ds
rna
prefer
substrat
carri
singl
nonhybrid
nucleotid
end
studi
togeth
increas
mutat
rate
observ
revers
engin
exondefici
mutant
strongli
suggest
involv
exon
uniqu
rna
proofread
mechan
allow
cov
safeguard
integr
unusu
larg
rna
genom
interestingli
show
effect
methyltransferas
activ
vitro
consid
import
protein
regul
viral
enzymat
activ
replicationtranscript
complex
assembl
constitut
attract
target
drug
design
program
context
combin
sever
approach
map
interact
molecular
level
use
extend
mutagenesi
approach
coupl
cellulo
bioluminesc
reson
energi
transfer
bret
studi
vitro
function
assay
identifi
continu
specif
surfac
involv
interact
key
surfac
residu
involv
interact
found
control
sarscov
exon
activ
also
appear
part
domain
interact
thu
possess
overlap
interact
surfac
activ
two
import
viral
enzym
revers
genet
experi
target
key
residu
domain
reveal
inde
critic
sarscov
replic
thu
valid
surfac
potenti
target
antivir
drug
develop
reagentsal
radioact
reagent
purchas
perkinelm
life
scienc
sadenosyllmethionin
purchas
new
england
biolab
plasmidsal
clone
experi
perform
use
gateway
technolog
invitrogen
bret
experi
plasmid
construct
describ
lugari
et
al
sarscov
express
plasmid
describ
previous
gene
also
clone
dualpromot
express
plasmid
describ
previous
backbon
sarscov
express
fusion
ntermin
streptagii
name
wherea
fuse
ntermin
hexahistidin
tag
name
singl
point
mutant
plasmid
gener
pcr
use
quikchang
sitedirect
mutagenesi
kit
stratagen
accord
manufactur
instruct
cell
culturehek
cell
grown
accord
atcc
recommend
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
mm
lglutamin
unitsml
penicillin
gml
streptomycin
cell
atcc
cultur
eagl
minim
essenti
medium
emem
lonza
fetal
calf
serum
paa
antibiot
bhktetsarsn
cell
cultur
eagl
minimum
essenti
medium
fetal
calf
serum
paa
antibiot
gml
bret
assayscel
plate
transfect
use
fugen
transfect
reagent
roch
appli
scienc
accord
manufactur
protocol
cell
plate
cell
per
well
h
transfect
transfect
made
ng
vector
variou
amount
vector
ng
complement
vector
total
g
dna
transfect
per
well
cell
incub
co
h
prior
bret
assay
bret
assay
perform
live
cell
accord
lugari
et
al
experi
transfect
alon
plu
peyfp
perform
control
coelenterazin
h
tebubio
ad
cell
final
concentr
cell
incub
min
room
temperatur
read
bret
measur
perform
sequenti
integr
luminesc
signal
nm
bret
ratio
defin
emiss
nm
emiss
nm
cf
emiss
nm
cf
correspond
emiss
nm
emiss
nm
renilla
luciferas
rluc
fusion
protein
express
alon
experiment
condit
experi
perform
least
three
time
bret
signal
normal
accord
accessori
purpl
protein
gene
express
nest
set
subgenom
mrna
schemat
structur
pdb
code
gener
use
pymol
softwar
zinc
ion
shown
green
sphere
residu
form
two
zinc
finger
label
depict
brown
stick
fluoresc
signal
mutant
compar
wild
type
antibodiesantigfp
antibodi
mix
clone
use
purchas
roch
appli
scienc
antirenilla
luciferas
antibodi
purchas
chemicon
secondari
antibodi
coupl
horseradish
peroxidas
purchas
dako
alexaconjug
antibodi
immunostain
jackson
immunoresearch
laboratori
express
purif
sarscov
proteinsexpress
purif
escherichia
coli
transform
untag
e
coli
carri
perform
previous
describ
sarscov
coexpress
perform
describ
debarnot
et
al
rna
synthesi
purificationsynthet
rna
purchas
jena
bioscienc
hplc
grade
rna
radiolabel
use
polynucleotid
kinas
new
england
biolab
p
atp
accord
manufactur
instruct
exonucleas
assayth
reaction
perform
describ
bouvet
et
al
briefli
incub
molecular
ratio
radiolabel
rna
oligo
min
reaction
stop
reaction
product
separ
denatur
polyacrylamid
gel
visual
use
phosphorimag
fluoresc
imag
analyz
fuji
rel
exon
activ
quantifi
use
imag
gaug
softwar
pulldown
assayfor
pulldown
assay
sarscov
coexpress
e
coli
use
dual
promotor
approach
system
sarscov
express
control
tet
promot
produc
protein
fusion
ntermin
streptagii
wherea
express
promot
carri
ntermin
tag
e
coli
cell
avidi
sa
franc
harbor
plyss
plasmid
novagen
transform
variou
express
vector
grown
medium
contain
antibiot
protein
express
induc
ad
isopropyl
gliter
anhydrotetracyclin
cell
incub
h
bacteri
cell
pellet
frozen
resuspend
lysi
buffer
mm
hepe
ph
mm
nacl
mm
mgso
supplement
mm
pmsf
gml
dnase
triton
sonic
clarif
protein
purifi
chromatographi
streptactinsepharos
iba
gmbh
germani
wash
high
salt
buffer
nacl
wash
low
salt
buffer
mm
nacl
bound
protein
elut
mm
ddesthiobiotin
bind
buffer
purifi
protein
analyz
quantifi
capillari
electrophoresi
calip
labchip
perkinelm
life
scienc
sarscov
revers
geneticsus
en
passant
recombin
recombin
mutagenesi
mutat
region
sarscov
isol
engin
prscv
deriv
contain
fulllength
cdna
copi
viral
genom
dna
bac
clone
linear
noti
extract
phenolchloroform
transcrib
mmessagemmachin
ambion
use
g
dna
templat
reaction
fulllength
viral
rna
precipit
licl
accord
manufactur
protocol
g
electropor
bhktetsarsn
cell
express
sarscov
n
protein
h
induct
doxycyclin
electropor
done
use
amaxa
nucleofector
lonza
nucleofector
kit
program
accord
manufactur
instruct
cell
mix
ratio
cell
seed
coverslip
immunofluoresc
microscopi
analysi
viru
product
mutant
launch
twice
independ
gener
bac
clone
work
live
sarscov
perform
insid
biosafeti
cabinet
biosafeti
level
facil
leiden
univers
medic
center
rtpcr
analysi
code
regionfresh
cell
infect
harvest
taken
h
post
transfect
cell
incub
overnight
intracellular
rna
isol
infect
cell
use
tripur
isol
reagent
roch
appli
scienc
describ
manufactur
instruct
amplifi
rtpcr
use
random
hexam
prime
rt
reaction
primer
pcr
amplif
region
region
amplifi
use
primer
primer
amplif
region
amplicon
sequenc
verifi
presenc
origin
mutat
andor
put
second
site
revers
experi
mutant
sign
viru
replic
observ
earli
time
point
h
post
transfect
use
either
immunofluoresc
microscopi
titrat
viral
progeni
one
experi
howev
cell
die
viral
infect
dish
use
obtain
h
posttransfect
harvest
materi
use
infect
fresh
cell
rna
isol
amplif
region
rtpcr
sequenc
product
reveal
origin
mutat
convert
immunofluoresc
microscopyto
monitor
progress
sarscov
infect
transfect
cell
coverslip
fix
variou
time
point
post
transfect
immunofluoresc
assay
done
previous
describ
protocol
use
rabbit
antiserum
mab
n
kindli
provid
ying
fang
south
dakota
state
univers
ref
express
level
n
bhktetsarsn
cell
much
lower
level
reach
infect
cell
possibl
discrimin
sarscovposit
neg
cell
titrat
viru
progeni
plaqu
reduct
assaysfor
plaqu
assay
cell
seed
cluster
infect
serial
dilut
pb
contain
deae
fc
supernat
transfect
cell
inoculum
remov
h
replac
overlay
avicel
fmc
biopolym
dmem
supplement
mm
hepe
fc
cell
incub
day
cell
layer
fix
formaldehyd
pb
stain
crystal
violet
visual
plaqu
titer
express
plaqu
form
unit
per
ml
plaqu
reduct
assay
essenti
perform
plaqu
assay
follow
modif
well
cluster
infect
amount
viru
plaqu
form
unit
per
well
subsequ
overlay
appli
contain
increas
concentr
sigma
rang
map
surfac
residu
involv
interact
recent
show
interact
induc
stimul
exon
activ
qualit
studi
pinpoint
residu
involv
interact
also
import
interact
regul
sarscov
activ
assess
overlap
interact
surfac
first
test
impact
mutat
interact
use
cellulo
bret
assay
overview
bret
strategi
setup
see
ref
mutant
fuse
c
terminu
enhanc
yellow
fluoresc
protein
eyfp
fuse
c
terminu
rluc
place
control
cytomegaloviru
promot
bret
signal
measur
human
hek
cell
h
plasmid
transfect
fig
express
level
mutant
quit
variabl
amount
transfect
plasmid
dna
mutant
adjust
achiev
compar
protein
express
level
fig
mutat
select
test
bret
assay
mainli
target
surfac
residu
describ
lugari
et
al
known
affect
prevent
interact
almost
mutant
test
bret
impair
interact
rel
bret
valu
suggest
involv
interact
fig
mutant
mutat
resid
outsid
interact
surfac
yield
bret
valu
compar
wildtyp
could
thu
use
neg
control
bret
assay
mutat
test
concern
surfac
residu
assum
alter
threedimension
structur
protein
support
h
n
heteronuclear
singl
quantum
correl
nmr
experi
lugari
et
al
three
mutant
howev
target
residu
close
involv
format
two
zinc
finger
fig
replac
residu
abrog
interact
bret
valu
probabl
due
misfold
therefor
discard
mutant
studi
final
mutant
show
figur
bret
character
interact
wildtyp
mutant
mammalian
cell
bret
interact
assay
perform
hek
cell
cotransfect
plasmid
express
mutant
express
plasmid
experi
perform
three
time
rel
interact
mutant
calcul
compar
interact
wildtyp
taken
bret
signal
normal
accord
fluoresc
signal
measur
mutant
compar
wildtyp
control
b
western
blot
analysi
confirm
similar
level
protein
express
two
interact
partner
level
determin
use
antiluciferas
antigfp
antibodi
respect
antiluciferas
antibodi
also
recogn
host
cell
protein
could
conveni
serv
load
control
cell
lysat
septemb
volum
number
reduct
interact
bret
valu
oppos
stimul
interact
reduc
interact
correl
loss
exon
activityw
next
perform
pulldown
assay
measur
bind
effici
mutant
vitro
fig
streptag
tag
coexpress
e
coli
purifi
use
streptactin
bead
wherea
copurifi
complex
subsequ
quantit
capillari
electrophoresi
set
residu
target
mutagenesi
includ
alanin
mutant
residu
surround
surfac
defin
bret
assay
neg
control
residu
posit
opposit
side
structur
mutant
test
bind
reduc
least
approxim
half
display
complet
loss
copurif
mutat
reduc
rel
bind
effici
compar
wildtyp
final
two
mutant
neg
control
interact
slightli
alter
vitro
fig
next
studi
function
import
residu
describ
stimul
exon
activ
capabl
mutant
protein
modul
exon
activ
assay
measur
hydrolysi
radiolabel
rna
oligonucleotid
mutant
describ
previous
rna
substrat
form
doublestrand
rna
structur
readili
degrad
complex
mutant
display
reduc
affin
judg
bret
analysi
vitro
bind
assay
show
reduc
stimul
exon
activ
compar
wildtyp
fig
bretidentifi
mutat
hamper
interact
caus
reduct
vitro
bind
exon
activ
assay
mutagenesi
alanin
residu
surround
surfac
defin
bret
studi
result
loss
least
bind
capac
significantli
affect
exon
activ
sever
mutant
abrog
interact
result
rel
exon
activ
suggest
import
role
residu
recognit
two
mutant
show
rel
bind
affect
exon
activ
less
dramat
exon
activ
respect
suggest
smaller
contribut
interact
final
mutant
use
neg
control
seem
involv
interact
exon
activ
vitro
bind
valu
close
also
confirm
inactiv
exon
activ
site
catalyt
residu
mutat
alanin
use
neg
control
result
complet
loss
exoribonucleas
activ
assay
bind
core
interact
surfac
interpret
result
map
residu
found
import
bret
assay
vitro
interact
analysi
exon
activ
assay
threedimension
bind
mutant
measur
vitro
pulldown
assay
purifi
affin
chromatographi
analyz
use
capillari
electrophoresi
amount
interact
quantifi
normal
use
bind
activ
compar
interact
wildtyp
arbitrarili
set
b
rel
exon
activ
presenc
panel
mutant
exon
activ
obtain
presenc
wildtyp
arbitrarili
set
experi
repeat
two
time
independ
residu
surround
surfac
defin
bret
assay
newli
includ
stage
studi
mark
asterisk
structur
pdb
code
fig
ac
respect
three
method
clearli
defin
common
surfac
interact
interestingli
previous
shown
part
surfac
also
involv
interact
surfac
well
conserv
among
coronavirus
assess
degre
overlap
interact
surfac
first
map
residu
involv
interact
identifi
threedimension
structur
fig
use
structur
complex
pdb
code
also
map
residu
involv
interact
purpos
highlight
residu
within
radiu
fig
area
correspond
bind
surfac
mark
structur
model
fig
figur
distinctli
highlight
fact
interact
surfac
substanti
overlap
surfac
interact
seem
extend
one
involv
interact
residu
involv
interact
play
critic
role
interact
structur
depict
fig
interact
surfac
cover
interact
surfac
extend
toward
upper
part
tabl
summar
data
obtain
interact
compar
data
previous
describ
interact
analysi
residu
involv
interact
essenti
sarscov
replicationa
select
mutat
describ
reverseengin
sarscov
genom
use
bacbas
fulllength
cdna
clone
recombin
viru
launch
chose
includ
mutat
affect
interact
target
interact
mutant
also
includ
shown
stronger
vitro
interact
compar
wildtyp
addit
phenotyp
control
construct
mutant
inactiv
exon
activ
addit
interact
knockout
mutant
made
residu
previous
shown
interact
crystal
structur
complex
substitut
alanin
mutant
virus
launch
electropor
vitro
transcrib
fulllength
rna
bhktetsarsn
cell
express
viral
nucleocapsid
protein
cell
transfect
effici
produc
progeni
virion
support
viral
spread
lack
receptor
use
viru
reason
transfect
cell
depict
white
surfac
represent
residu
found
involv
interact
vivo
bret
assay
effect
color
orang
b
residu
found
involv
interact
accord
vitro
bind
capac
pulldown
assay
effect
color
green
c
residu
found
involv
interact
basi
exon
activ
reduct
color
dark
blue
residu
could
mutat
without
significantli
alter
interact
exon
activ
effect
depict
purpl
residu
test
bret
experi
compar
assay
display
gray
nd
figur
gener
use
pymol
mix
sarscovsuscept
cell
replic
mutant
virus
studi
differ
time
point
use
immunofluoresc
microscopi
progeni
viru
titrat
plaqu
assay
viru
mutant
two
independ
mutant
fulllength
cdna
clone
gener
found
yield
ident
result
revers
genet
data
summar
tabl
plaqu
phenotyp
replicationcompet
mutant
shown
fig
vivo
data
fulli
support
notion
residu
involv
interact
import
sarscov
replic
cell
cultur
three
mutat
abolish
interact
vitro
result
nonviabl
viru
phenotyp
wherea
fourth
mutat
type
pseudorevert
late
time
point
one
two
experi
origin
mutat
chang
valin
h
post
transfect
mutat
decreas
block
interact
exon
activ
vitro
yield
crippl
viru
reduc
titer
compar
wildtyp
control
h
post
transfect
plaqu
produc
viru
slightli
smaller
wildtyp
plaqu
heterogen
size
compar
wildtyp
viru
mutant
fig
nonviabl
laterevert
phenotyp
sever
mutant
attribut
sole
reduct
lack
exon
activ
measur
vitro
tabl
exon
activ
site
mutant
despit
crippl
clearli
replic
compet
fig
also
previous
report
eckerl
et
al
interact
appar
play
less
critic
role
basic
cov
replic
also
illustr
replicationcompet
phenotyp
mutant
display
smallplaqu
phenotyp
gave
reduc
viru
titer
h
post
transfect
plaqu
phenotyp
similar
activ
site
mutant
although
viru
titer
latter
mutant
log
lower
replicationcompet
crippl
phenotyp
activ
site
mutant
compar
correspond
mutant
previous
describ
sarscov
mhv
postul
convers
shown
white
surfac
represent
residu
significantli
affect
interact
mutat
color
red
decreas
bret
valu
bind
affin
exon
activ
residu
impair
interact
smaller
effect
mutat
bind
affin
exon
activ
wild
type
shown
orang
b
represent
residu
involv
interact
structur
complex
pdb
code
shown
schemat
represent
color
cyan
residu
present
within
radiu
depict
yellow
c
schemat
represent
function
interact
surfac
red
rectangl
dark
yellow
squar
base
lugari
et
al
structur
interact
surfac
depict
dash
yellow
rectangl
overlap
function
interact
surfac
depict
pale
green
figur
gener
use
pymol
cap
cap
viral
mrna
play
import
role
escap
innat
immun
recognit
essenti
viral
replic
per
se
mutat
decreas
interact
increas
interact
vitro
gave
rise
viru
titer
plaqu
size
similar
wildtyp
control
result
strongli
suggest
replic
defect
nonviabl
mutant
caus
reduct
stimul
either
exon
activ
mtase
function
appar
core
domain
play
pleiotrop
role
viru
replic
also
previous
deduc
data
obtain
mhv
model
given
fact
compromis
interact
stimul
activ
vitro
investig
possibl
mutat
increas
sarscov
mutat
frequenc
mutat
phenotyp
manner
similar
report
exon
knockout
mutant
test
whether
mutant
also
display
phenotyp
plaqu
reduct
assay
perform
presenc
increas
concentr
mutagen
previous
report
increas
sensit
readili
observ
even
lowest
dose
test
exon
knockout
mutant
includ
posit
control
experi
fig
howev
mutant
found
equal
insensit
drug
wildtyp
viru
highest
dose
test
mutat
test
revers
genet
experi
shown
bold
underlin
charact
nd
defin
septemb
volum
number
slight
reduct
plaqu
size
number
observ
wildtyp
viru
mutant
fig
observ
inconsist
hypothesi
mutant
would
mutat
phenotyp
markedli
increas
sensit
mutagenlik
sarscov
exon
activ
recent
shown
strongli
stimul
presenc
interact
partner
featur
like
highli
relev
uniqu
rna
proofread
mechan
thought
allow
coronavirus
reliabl
replic
long
rna
genom
accordingli
replac
exon
catalyt
residu
creat
mutat
phenotyp
may
long
run
threaten
cov
genet
stabil
surviv
studi
identifi
residu
involv
interact
bret
methodolog
consid
one
versatil
techniqu
studi
dynam
proteinprotein
interact
live
cell
well
vitro
pulldown
enzymat
assay
allow
map
key
residu
involv
format
complex
stimul
exon
activ
fig
interestingli
larg
major
mutant
interact
disrupt
lost
exonactiv
potenti
reveal
critic
natur
interact
exon
activ
surfac
deduc
involv
interact
conserv
across
four
genera
coronavirida
subfamili
fig
overlap
interact
surfac
previous
describ
fig
ref
molecul
may
thu
act
platform
recruit
replicationtranscript
complex
either
boost
exon
activ
switch
activ
although
overlap
interact
surfac
suggest
exclus
interact
either
protein
produc
much
higher
rate
due
fact
unlik
encod
upstream
ribosom
frameshift
site
even
though
littl
known
rel
turnov
cov
nsp
gener
although
may
addit
bind
partner
remain
identifi
fair
assum
level
infect
cell
substanti
higher
impli
latter
two
protein
would
necessarili
compet
bind
thu
complex
may
coexist
possibl
part
larger
nsp
assembl
engag
differ
step
viral
rna
synthesi
one
residu
particular
interest
aromat
natur
play
crucial
role
interact
activ
activ
residu
specif
sarscov
phenylalanin
coronaviru
homologu
fig
mutat
result
enhanc
bind
correl
increas
activ
residu
hypothes
finetun
strength
interact
howev
underli
mechan
could
clearli
defin
molecular
level
even
use
structur
complex
studi
show
involv
interact
mutat
interfer
bind
decreas
exon
activ
vitro
may
explain
tyrosin
residu
select
cours
sarscov
evolut
wherea
phenylalanin
prefer
posit
cov
balanc
rel
affin
nevertheless
revers
genet
experi
phenotyp
mutant
viru
found
similar
wildtyp
viru
indic
presenc
phenylalanin
residu
posit
strongli
affect
viral
replic
type
short
term
cell
cultur
experi
includ
studi
complet
inactiv
cov
exon
function
yield
crippl
replic
viru
ref
confirm
studi
highli
surpris
sever
mutat
disrupt
interact
prove
lethal
clearli
nonviabl
phenotyp
mutant
explain
loss
exon
activ
alon
rais
import
question
function
complex
cov
replic
bifunct
enzym
interact
may
also
influenc
critic
methyltransferas
activ
although
posit
neg
influenc
activ
observ
vitro
assay
altern
complex
may
addit
yet
unknown
function
vital
cov
replic
previous
base
mhv
studi
indirect
role
proteolyt
process
replicas
polyprotein
viral
rna
synthesi
propos
conceiv
nonviabl
phenotyp
sever
sarscov
mutant
present
studi
could
attribut
critic
influenc
one
yet
poorli
defin
addit
function
mani
sarscov
residu
found
affect
interact
viral
replic
correspond
residu
local
within
core
previous
defin
donaldson
plaqu
reduct
assay
perform
presenc
increas
concentr
well
infect
amount
viru
cell
layer
overlaid
semisolid
medium
contain
indic
increas
concentr
cell
layer
incub
day
fix
stain
reveal
plaqu
format
like
wildtyp
viru
mutant
insensit
dose
hand
plaqu
size
number
mutant
exon
knockout
mutant
known
exhibit
mutat
phenotyp
strongli
reduc
even
lowest
concentr
test
septemb
volum
number
et
al
mhv
core
appear
toler
mutat
nonviabl
phenotyp
mhv
mutant
test
donaldson
et
al
seem
reflect
import
interact
surfac
coronavirus
instanc
conserv
residu
target
mhv
found
critic
viru
replic
line
data
vitro
interact
studi
present
sarscov
still
nonviabl
phenotyp
could
also
explain
altern
scenario
like
surfac
involv
anoth
function
critic
coronavirus
replic
avail
data
lead
us
propos
specif
hot
spot
residu
within
around
core
target
disrupt
interact
inhibit
exon
activ
andor
function
potenti
interf
cov
replic
strikingli
residu
highli
conserv
across
coronavirus
includ
recent
emerg
potenti
lifethreaten
merscov
fig
consid
import
viru
replic
highlight
studi
repres
attract
target
anticoronaviru
drug
discoveri
specif
molecul
peptid
target
describ
surfac
inhibit
interact
could
develop
reduc
prevent
coronaviru
replic
well
conserv
among
coronavirus
compound
could
use
treatment
prophylact
approach
prevent
merscov
infect
possibl
outburst
sarscov
newli
emerg
lethal
coronaviru
